Roskilde County Hospital Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00216827
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre for Anaesthesiological Research, Department of Anaesthesiology, Zealand University Hospital | Department of Medicine, Division of Nephrology, Roskilde County Hospital | Roskilde Hospital, Division of Dermatology | Roskilde University Hospital, Medicinsk afdeling

Active Ingredients

Drugs in Phase 4 Trials (1)

dexamethasone (1 trial)

Drugs in Phase 3 Trials (3)

betamethasone (celestone) (1 trial)

calcipotriene (dovonex) (1 trial)

iron oligosaccharide (1 trial)

Drugs in Phase 2 Trials (1)

magnesium oxide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 3)

Kidney Diseases (Phase 2)

Psoriasis (Phase 3)

Renal Insufficiency, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5